Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Leonardo DRS (DRS) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Leonardo DRS (DRS) over the last 6 years, with Q3 2025 value amounting to $309.0 million.

  • Leonardo DRS's Cash & Equivalents rose 5606.06% to $309.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.0 million, marking a year-over-year increase of 5606.06%. This contributed to the annual value of $598.0 million for FY2024, which is 2805.14% up from last year.
  • According to the latest figures from Q3 2025, Leonardo DRS's Cash & Equivalents is $309.0 million, which was up 5606.06% from $278.0 million recorded in Q2 2025.
  • Leonardo DRS's 5-year Cash & Equivalents high stood at $598.0 million for Q4 2024, and its period low was $30.0 million during Q1 2021.
  • In the last 5 years, Leonardo DRS's Cash & Equivalents had a median value of $160.0 million in 2024 and averaged $199.2 million.
  • As far as peak fluctuations go, Leonardo DRS's Cash & Equivalents tumbled by 4927.54% in 2023, and later skyrocketed by 32571.43% in 2024.
  • Leonardo DRS's Cash & Equivalents (Quarter) stood at $240.0 million in 2021, then increased by 27.5% to $306.0 million in 2022, then soared by 52.61% to $467.0 million in 2023, then rose by 28.05% to $598.0 million in 2024, then crashed by 48.33% to $309.0 million in 2025.
  • Its Cash & Equivalents was $309.0 million in Q3 2025, compared to $278.0 million in Q2 2025 and $380.0 million in Q1 2025.